• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Newsletter Sign Up
Contact
  • Home
  • News
  • Fairs & Events
  • 25th APIC/CEFIC Global GMP & Regulatory API Conference: Challenges for China Registration of API

25th APIC/CEFIC Global GMP & Regulatory API Conference: Challenges for China Registration of API

API Registration in China
Thursday, 25 August 2022 / Published in Fairs & Events, News, Webinars

25th APIC/CEFIC Global GMP & Regulatory API Conference: Challenges for China Registration of API

China registration of API (active pharmaceutical ingredients) support companies applying for drug marketing authorizations in reference to their DMF (Drug Master File) data.

Companies with business in China should always be aware of the risks involved and keep themselves informed about the latest changes with the pharmaceutical requirements in order to stay compliant in China. The webinar “Challenges for China Registration of API” is part of the 25th APIC/CEFIC Global GMP & Regulatory API Conference held live in Amsterdam and streamed online.

Click here for detailed information about this leading API event in Europe.

The webinar informs you about the current API regulatory framework in China, and provides analysis and comparison between EU and China markets.

Date and Time

Session E on October 27, 2022, 8:30am – 5:00pm (CEST)

Program Content

  • Organizations and Regulations
  • Introduction of the complete process with timeline and fees
  • Testing at NIFDC in China
  • Introduction of application documents
  • Comparison EU & China
  • Common deficiencies from the perspective of a EU manufacturer

Click here to download the PDF version of the conference programme.

Speaker

  • Mr. Stefan Fischer – Managing Director of the Cisema Group
  • Mr. Guo Ning – General Manager of Cisema Beijing 

Our Services

As part of the registration of pharmaceuticals, manufacturers must submit the DMF (Drug Master File) number of the pharmaceutical packaging and ingredients. Cisema can support the applicant during the preparation of the supplementary dossier and the second NMPA technical evaluation. We can help provide the required technical documents or test data in this supplementary phase. In addition, Cisema can also support for the following:

  • Advice on applicable legislation and regulations.
  • Determining whether your products need NMPA approval.
  • Analysis of ingredients for compliance with Chinese regulations.
  • Legal representation in China as NMPA Legal Agent for registration and regulatory affairs and protecting your independence.
  • Application for China NMPA registration.
  • Provision of complete document checklist and templates, including advice on the correct completion.
  • Translations and notarizations.
  • Provision of comprehensive test sample list.
  • Close follow up of your sample tests in China.
  • Communication and coordination between you and the Chinese authorities in technical and cultural terms.
  • Provide response proposal of technical reviews by CDE.
  • Assist site inspection initiated by CDE & CFDI.
  • Follow-up support during the NMPA application of pharmaceuticals containing API or Drug.

If you would like assistance in the application of your API registration or other pharmaceutical projects, contact Cisema.

Cisema is a CRO and regulatory affairs consultant for China and has 12 offices globally with nearly 100 full-time employees.

GET IN TOUCH

🌐 Send us your enquiry
📚 Request our whitepapers
📣 Sign up for our newsletter

What you can read next

Hong Kong drug and medical device registrations
Hong Kong drug and medical device registrations: Latest updates including China GBA pathways | Upcoming Webinar
New Clinical Trial Exemption List
China Regulations on the Supervision and Administration of Children’s Cosmetics (Draft for soliciting opinions)

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • Submission of safety information for cosmetics ingredients

    Submission of safety information for cosmetics raw materials – Draft guidelines issued

    Submission of safety information for cosmetics ...
  • avoid animal testing in Chinaweb-2023

    How to avoid animal testing in China for cosmetics | Cisema Webinar

    China’s beauty and cosmetic market has be...
  • guidelines for medical devices registration

    Guidelines for medical devices registration in China – New development plans in 2023

    Guidelines for medical devices registration in ...
  • China DMF of API

    China DMF of API, Excipient & Packaging Materials: Market & Regulatory | Cisema Webinar

    “China DMF of API, Excipient & Packag...
  • pre-phase III drug clinical trial meeting guidelines

    Pre-phase III drug clinical trial meeting guidelines released

    Pre-phase III drug clinical trial meeting guide...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP